Quarterly report [Sections 13 or 15(d)]

Condensed Balance Sheets

v3.25.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2025
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 10,354,773 $ 11,627,849
Grant receivable 9,825 73,218
Prepaid expenses 170,771 261,439
Total current assets 10,535,369 11,962,506
Other assets:    
Loan commitment fees 165,670 183,110
Total assets 10,701,039 12,145,616
Current liabilities:    
Accounts payable 607,539 224,175
Accrued expenses 356,282 263,513
Total liabilities 963,821 487,688
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at September 30, 2025 and June 30, 2025
Common stock, $0.001 par value; 75,000,000 shares authorized and 41,084,731 shares issued and outstanding at September 30, 2025 and June 30, 2025 41,086 41,086
Additional paid-in capital 85,742,993 85,505,349
Accumulated deficit (76,046,861) (73,888,507)
Total stockholders’ equity 9,737,218 11,657,928
Total liabilities and stockholders’ equity $ 10,701,039 $ 12,145,616